ABT-046

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameABT-046
Drug Alias NameABT-046
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol O-acyltransferase 1 inhibitors
TargetsDiacylglycerol O-acyltransferase 1
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesAbbott Laboratories
Inactive CompaniesN/A
Active IndicationsHyperlipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A